What is the difference between adrenaline (epinephrine) and noradrenaline (norepinephrine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Difference Between Adrenaline and Noradrenaline

Adrenaline (epinephrine) is a much more powerful cardiac stimulant with predominant β-adrenergic effects, while noradrenaline (norepinephrine) acts primarily as a vasoconstrictor with predominant α-adrenergic effects. 1

Chemical Structure

The fundamental difference is structural: norepinephrine lacks a methyl group on the nitrogen atom that is present in epinephrine 2, 3. This single molecular difference accounts for their distinct receptor binding profiles and physiological effects.

Receptor Activity and Cardiovascular Effects

Norepinephrine (Noradrenaline)

  • Predominantly α-adrenergic agonist with some β1 activity 4
  • Increases blood pressure primarily through vasoconstriction (increased systemic vascular resistance)
  • Cardiac effects are inconsistent and time-dependent, with direct positive chronotropic effects often counterbalanced by vagal reflex from increased blood pressure 1
  • Increases stroke volume and coronary blood flow via β2-receptor stimulation, but these effects are often transient 1
  • Preferentially acts on β1-adrenoceptors for metabolic effects 5

Epinephrine (Adrenaline)

  • Predominantly β-adrenergic agonist (both β1 and β2) with some α activity 4
  • Increases blood pressure through increased cardiac output without significant change in systemic vascular resistance 4
  • Dramatically increases cardiac work and oxygen consumption 1
  • Accelerates heart rate, improves cardiac conduction, stimulates relaxation rate, and reinforces systolic efficiency 1
  • Preferentially acts on β2-adrenoceptors, producing up to 10 times more cyclic AMP per receptor stimulation than β1 6
  • Higher risk of tachycardia and arrhythmias compared to norepinephrine 1

Tissue-Specific Vascular Effects

The selectivity differs markedly by tissue 5:

  • Epinephrine: Causes significant vasoconstriction in adipose tissue at plasma concentrations as low as 5 nM, but minimal effect on skeletal muscle
  • Norepinephrine: Causes significant vasoconstriction in skeletal muscle at 5 nM, but no vasoconstrictor effect in adipose tissue

Metabolic Effects

Epinephrine is more potent for increasing plasma cyclic AMP and glucose, while norepinephrine is more potent for increasing plasma glycerol 5. This reflects epinephrine's preferential β2 action versus norepinephrine's preferential β1 action.

Clinical Context in Shock States

In septic shock management, norepinephrine is recommended as first-line by international guidelines 7. When comparing the two agents:

  • Similar mortality outcomes in adults 8
  • Norepinephrine associated with lower lactate concentrations at 24 hours 8
  • Epinephrine associated with higher risk of rearrest in post-cardiac arrest patients 7
  • In pediatric septic shock, recent data suggests epinephrine may be associated with greater 30-day mortality (3.7% vs 0%) 9

Physiological Roles

As Neurotransmitters and Hormones 10:

  • Norepinephrine: Primary neurotransmitter of the sympathetic nervous system and CNS (locus coeruleus); regulates vigilance, cardiovascular tone
  • Epinephrine: Primarily a hormone released by the adrenal medulla; orchestrates acute stress response and metabolic homeostasis

Clinical Pitfalls

  • Do not assume equivalent hemodynamic effects: Epinephrine's powerful β effects mean it will increase cardiac work substantially more than norepinephrine 1
  • Arrhythmia risk: Epinephrine carries significantly higher arrhythmia risk, particularly important in patients with ischemic heart disease 1
  • Metabolic consequences: Epinephrine causes more pronounced metabolic derangements that may complicate shock management 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.